Penumbra
PEN
C$342.05
Share price
-2.32%
Change (1 day)
41.23%
Change (1 year)
Categories
Penumbra, Inc., is an American company that develops, manufactures and sells medical devices for neurovascular and vascular medicine applications.
Penumbra (PEN) - Total liabilities
Total liabilities on the balance sheet as of March 2025 : C$0.51 Billion
According to Penumbra's latest financial reports the company's total liabilities are C$0.51 Billion. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Penumbra - Total liabilities on balance sheet (from 2014 to 2025)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2024-12-31 | C$0.54 B | 9.59% |
| 2023-12-31 | C$0.50 B | -0.85% |
| 2022-12-31 | C$0.50 B | 36.44% |
| 2021-12-31 | C$0.36 B | 56.69% |
| 2020-12-31 | C$0.23 B | 0.28% |
| 2019-12-31 | C$0.23 B | 86.69% |
| 2018-12-31 | C$0.12 B | 31.55% |
| 2017-12-31 | C$95.87 M | 71.06% |
| 2016-12-31 | C$56.04 M | 28.98% |
| 2015-12-31 | C$43.45 M | -72% |
| 2014-12-31 | C$0.15 B | 84.08% |
| 2013-12-31 | C$84.31 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Inari Medical
NARI | C$0.35 B | -31.00% | 🇺🇸 USA |
 Merit Medical MMSI | C$1.41 B | 173.26% | 🇺🇸 USA |